Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Health Policy (Amsterdam, Netherlands)|September 21, 2024
The modernisation of newborn screening as a pan-European challenge - An international delphi studySandra Gillner, Gulcin Gumus, Edith Gross, et al.
Respiratory Research|July 20, 2017
Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trialClaus F Vogelmeier, Mina Gaga, Maryam Aalamian-Mattheis, et al.
Plos One|June 20, 2020
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS studyIan Pearce, Andreas Clemens, Michael H Brent, et al.
Ophthalmology Science|March 19, 2026
Expert Consensus on Characteristics, Etiology, and Management of Chorioretinal Atrophy in Patients Treated with Voretigene NeparvovecM Dominik Fischer, Isabelle Audo, David Gaucher, et al.
Retina (Philadelphia, Pa.)|January 27, 2023
IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER StudiesDavid Eichenbaum, David M Brown, Michael Ip, et al.
Thrombosis and Haemostasis|February 8, 2013
Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal diseaseDmytro Khadzhynov, Frank Wagner, Stephan Formella, et al.
Plos One|January 22, 2020
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS studyRobin D Hamilton, Andreas Clemens, Angelo Maria Minnella, et al.
Respiratory Research|January 13, 2017
Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled studyJoerg Salomon, Daiana Stolz, Guido Domenighetti, et al.
Asian Journal of Surgery|May 5, 2016
Thromboprophylaxis with dabigatran after total hip arthroplasty in Indian patients: A subanalysis of a double-blind, double-dummy, randomized RE-NOVATE II studyRajesh Malhotra, Sushrut Babhulkar, Kumar Behera Sanjib, et al.
American Heart Journal|March 1, 2014
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillationMenno V Huisman, Gregory Y H Lip, Hans C Diener, et al.
Pageof 9